Evergreen, patient structure enables flexible checks and long holds for formative-stage healthcare companies (>$1M ARR), combining deep sector expertise, VC, PE and real estate platform plus cash-yielding kiosks. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Invests at or before seed in nascent-stage life sciences, building companies via 4:59 Initiative, with partners taking short-term operating roles and focusing on capital efficiency and faster timelines. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Is dedicated to dynamic teams with sound fundamentals building market-leading consumer brands. The firm continues to build its presence across the venture capital landscape.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Nascent-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech, delivering specialized neuro+AI+delivery expertise that bridges physical clinics and cutting-edge technologies. With a disciplined investment approach, the team drives value for both founders and investors.
